Shenzhen Kangtai Biological Products Co Ltd (300601) — Net Asset Quality Index
Shenzhen Kangtai Biological Products Co Ltd (300601) has a Net Asset Quality Index of 69.1% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥13.99 Billion minus total liabilities of CN¥4.32 Billion yields net assets of CN¥9.67 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See 300601 cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
Shenzhen Kangtai Biological Products Co Ltd Net Asset Quality Index Over Time (2012–2025)
This chart shows how Shenzhen Kangtai Biological Products Co Ltd's Net Asset Quality Index has evolved across 14 annual periods from 2012 to 2025. As of March 2026, the index stands at 69.1%, representing net assets of CN¥9.67 Billion against total assets of CN¥13.99 Billion CNY. Explore 300601 cash flow metrics to assess how effectively this company generates cash.
Annual Net Asset Quality Index for Shenzhen Kangtai Biological Products Co Ltd (2012–2025)
The table below presents the year-by-year Net Asset Quality Index for Shenzhen Kangtai Biological Products Co Ltd from 2012 to 2025, covering 14 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see market cap of Shenzhen Kangtai Biological Products Co .
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 68.3% | CN¥9.63 Billion | CN¥14.10 Billion | CN¥4.46 Billion | ▲ +2.0 pp |
| 2024 | 66.3% | CN¥9.66 Billion | CN¥14.56 Billion | CN¥4.90 Billion | ▲ +3.1 pp |
| 2023 | 63.3% | CN¥9.54 Billion | CN¥15.09 Billion | CN¥5.54 Billion | ▼ -1.9 pp |
| 2022 | 65.2% | CN¥8.99 Billion | CN¥13.79 Billion | CN¥4.80 Billion | ▲ +0.4 pp |
| 2021 | 64.8% | CN¥9.17 Billion | CN¥14.15 Billion | CN¥4.98 Billion | ▼ -13.1 pp |
| 2020 | 77.9% | CN¥7.46 Billion | CN¥9.58 Billion | CN¥2.12 Billion | ▲ +8.2 pp |
| 2019 | 69.7% | CN¥2.75 Billion | CN¥3.95 Billion | CN¥1.20 Billion | ▲ +14.7 pp |
| 2018 | 55.0% | CN¥1.84 Billion | CN¥3.34 Billion | CN¥1.50 Billion | ▲ +6.5 pp |
| 2017 | 48.4% | CN¥1.07 Billion | CN¥2.21 Billion | CN¥1.14 Billion | ▲ +2.5 pp |
| 2016 | 45.9% | CN¥735.00 Million | CN¥1.60 Billion | CN¥865.90 Million | ▼ -2.6 pp |
| 2015 | 48.5% | CN¥647.12 Million | CN¥1.33 Billion | CN¥686.71 Million | ▲ +5.0 pp |
| 2014 | 43.5% | CN¥583.81 Million | CN¥1.34 Billion | CN¥758.25 Million | ▲ +9.9 pp |
| 2013 | 33.6% | CN¥372.17 Million | CN¥1.11 Billion | CN¥734.74 Million | ▼ -4.3 pp |
| 2012 | 37.9% | CN¥431.21 Million | CN¥1.14 Billion | CN¥705.50 Million | — |